NCT05312398 2025-05-25CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment RegimenUniversity of Campania Luigi VanvitelliPhase 2 Active not recruiting219 enrolled